GO:0050560 aspartate-tRNA(Asn) ligase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050560 describes aspartate-tRNA(Asn) ligase activity, a nondiscriminating aminoacyl-tRNA synthetase activity that attaches L-aspartate to tRNA(Asx) using ATP.
• This activity is essential in organisms that lack asparagine-tRNA synthetase and instead rely on Asp-tRNA(Asn) formation followed by transamidation to generate Asn-tRNA(Asn).
• The catalytic reaction produces aspartyl-tRNA(Asx), diphosphate, and AMP, and is driven by ATP hydrolysis.
• Key structural determinants include the anticodon-binding domain and a conserved proline in the anticodon-binding loop that influence tRNA(Asn) recognition.
• In pathogens such as Helicobacter pylori, Plasmodium falciparum, and Acidithiobacillus ferrooxidans, this activity is part of a tRNA-dependent amino acid biosynthesis pathway that is a potential drug target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes encoding this activity and its partners.
Description
GO:0050560, aspartate-tRNA(Asn) ligase activity, is a molecular function in which an enzyme catalyzes the attachment of L-aspartate to tRNA(Asx) in an ATP-dependent reaction, yielding aspartyl-tRNA(Asx), diphosphate, and AMP. This activity is also known as nondiscriminating aspartyl-tRNA synthetase activity because the same enzyme can charge both tRNA(Asp) and tRNA(Asn) with aspartate. In many bacteria and some parasites, the aspartyl-tRNA(Asn) product is subsequently converted to asparaginyl-tRNA(Asn) by a tRNA-dependent amidotransferase, providing a route to decode asparagine codons without a dedicated asparagine-tRNA synthetase. Researchers study this activity to understand genetic code flexibility, tRNA recognition, and aminoacyl-tRNA synthetase evolution. It is also of applied interest because the pathway is essential in several pathogens and differs from the corresponding human machinery, making it a candidate for selective inhibition.
aspartate-tRNA(Asn) ligase activity At A Glance
| GO ID | GO:0050560 |
|---|---|
| GO term | aspartate-tRNA(Asn) ligase activity |
| Ontology | molecular_function |
| Synonym | aspartate-tRNAAsn ligase activity; L-aspartate:tRNAAsx ligase (AMP-forming); nondiscriminating aspartyl-tRNA synthetase activity |
| Major function | ATP-dependent attachment of L-aspartate to tRNA(Asx), forming aspartyl-tRNA(Asx) |
| Reaction | tRNA(Asx) + L-aspartate + ATP = aspartyl-tRNA(Asx) + diphosphate + AMP |
| Substrates | tRNA(Asx), L-aspartate, ATP |
| Products | aspartyl-tRNA(Asx), diphosphate, AMP |
| Related pathway | tRNA-dependent asparagine biosynthesis via Asp-tRNA(Asn) transamidation |
What Is GO:0050560?
Aspartate-tRNA(Asn) ligase activity (GO:0050560) is the catalysis of the reaction: tRNA(Asx) + L-aspartate + ATP = aspartyl-tRNA(Asx) + diphosphate + AMP. In this reaction, the enzyme activates aspartate with ATP and transfers it to the 3' end of a tRNA that can be either tRNA(Asp) or tRNA(Asn), which is why the activity is called nondiscriminating. The resulting aspartyl-tRNA(Asn) is not used directly for protein synthesis; instead, it is typically converted to asparaginyl-tRNA(Asn) by a transamidation reaction, allowing asparagine codons to be translated.
Why Is aspartate-tRNA(Asn) ligase activity Important in Cell Biology?
Aspartate-tRNA(Asn) ligase activity is important because it enables organisms to decode asparagine codons through an indirect pathway that couples aminoacyl-tRNA synthesis to tRNA-dependent amino acid modification. This activity also illustrates how aminoacyl-tRNA synthetases can be nondiscriminating, charging more than one tRNA species, which has implications for tRNA recognition and genetic code evolution. In pathogens, the pathway is essential and structurally distinct from host enzymes, making it a target for inhibitor development. For researchers, the activity provides a tractable system to dissect active-site chemistry, anticodon recognition, and interdomain communication.
• Provides a route to asparaginyl-tRNA(Asn) in organisms lacking asparagine-tRNA synthetase.
• Represents a nondiscriminating aminoacyl-tRNA synthetase activity that charges both tRNA(Asp) and tRNA(Asn).
• Serves as a model for studying tRNA recognition and anticodon-binding domain function.
• Is essential in pathogens such as Helicobacter pylori and Plasmodium falciparum, supporting drug discovery.
• Contributes to understanding of genetic code flexibility and tRNA-dependent amino acid biosynthesis.
• Enables mechanistic studies of ATP-dependent amino acid activation and transfer.
• Offers a target for reaction hijacking and inhibitor design.
• Supports comparative enzymology across bacteria and parasites.
Molecular Mechanism of aspartate-tRNA(Asn) ligase activity
Substrate recognition and tRNA binding
In simple terms: The enzyme first grabs the tRNA and the amino acid it needs to attach.
Aspartate-tRNA(Asn) ligase activity requires binding of tRNA(Asx) and L-aspartate. The enzyme recognizes structural features of the tRNA, including the anticodon region, and a conserved proline in the anticodon-binding loop is important for tRNA(Asn) recognition in vivo. Anticodon-binding domain swapping experiments have shown that this domain contributes to tRNA specificity and catalytic activity. The nondiscriminating nature of the enzyme allows it to interact with both tRNA(Asp) and tRNA(Asn), although the active site may engage these tRNAs differently.
ATP-dependent aspartate activation
In simple terms: ATP is used to activate aspartate so it can be attached to the tRNA.
The catalytic mechanism follows the typical aminoacyl-tRNA synthetase two-step reaction. First, L-aspartate reacts with ATP to form an aspartyl-adenylate intermediate with release of diphosphate. This step is supported by inhibition studies using L-aspartol adenylate, which mimics the adenylate intermediate and reveals differences in how the active site interacts with tRNA(Asp) versus tRNA(Asn). The overall reaction produces aspartyl-tRNA(Asx) and AMP.
Transfer of aspartate to tRNA
In simple terms: The activated aspartate is transferred onto the tRNA, forming aspartyl-tRNA.
In the second step, the aspartyl group is transferred to the 3' end of tRNA(Asx), yielding aspartyl-tRNA(Asx) and AMP. This activity is described by the reaction tRNA(Asx) + L-aspartate + ATP = aspartyl-tRNA(Asx) + diphosphate + AMP. The enzyme is nondiscriminating because it can form aspartyl-tRNA(Asn) as well as aspartyl-tRNA(Asp). The resulting aspartyl-tRNA(Asn) is subsequently used by a tRNA-dependent amidotransferase to produce asparaginyl-tRNA(Asn).
Coupling to transamidation for asparagine decoding
In simple terms: The aspartate attached to tRNA(Asn) is later converted to asparagine so the ribosome can read asparagine codons.
In organisms that use this pathway, aspartyl-tRNA(Asn) is not used directly in translation. Instead, a dual-specific Glu-tRNA(Gln) and Asp-tRNA(Asn) amidotransferase converts aspartyl-tRNA(Asn) to asparaginyl-tRNA(Asn), which then decodes asparagine codons. The amidotransferase uses glutamine or another amide donor and has a kinase activity that is sensitive to distal mutations in its putative ammonia tunnel, highlighting the structural coupling between the synthetase and amidotransferase steps.
Regulation and inhibitor sensitivity
In simple terms: The activity can be turned down or blocked by small molecules that mimic reaction intermediates.
Aspartate-tRNA(Asn) ligase activity is sensitive to inhibitors that mimic the aminoacyl-adenylate intermediate, such as L-aspartol adenylate, which inhibits a nondiscriminating aspartyl-tRNA synthetase and reveals differences between its interactions with tRNA(Asp) and tRNA(Asn). Reaction hijacking inhibition has been demonstrated for a related asparagine tRNA synthetase in Plasmodium falciparum, showing that this class of enzymes can be targeted with pro-drugs that are activated by the synthetase. A single amino acid substitution can alter activity and specificity in Plasmodium falciparum aspartyl and asparaginyl-tRNA synthetases, indicating that catalytic properties are finely tuned.
Key Genes Involved in GO:0050560 aspartate-tRNA(Asn) ligase activity
The genes and proteins below are directly implicated in aspartate-tRNA(Asn) ligase activity or its coupled transamidation pathway, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| aspS (bacterial aspartyl-tRNA synthetase) | Encodes the nondiscriminating aspartyl-tRNA synthetase that can charge tRNA(Asn) with aspartate | Model for studying tRNA(Asn) recognition and nondiscriminating activity |
| AspRS (Helicobacter pylori) | Aspartyl-tRNA synthetase that provides Asp-tRNA(Asn) for transamidation | Used to study coupling with GatCAB amidotransferase and ammonia tunnel mutations |
| PfAspRS (Plasmodium falciparum aspartyl-tRNA synthetase) | Nondiscriminating synthetase that forms Asp-tRNA(Asn) | Target for antimalarial inhibitor design and specificity studies |
| PfAsnRS (Plasmodium falciparum asparaginyl-tRNA synthetase) | Related synthetase whose inhibition by reaction hijacking has been demonstrated | Provides insight into inhibitor strategies for this enzyme family |
| gatA | Amidotransferase subunit that converts Asp-tRNA(Asn) to Asn-tRNA(Asn) | Essential for the indirect asparagine pathway |
| gatB | Amidotransferase subunit involved in ammonia transfer and catalysis | Mutations in the putative ammonia tunnel affect kinase activity |
| gatC | Amidotransferase subunit that supports complex assembly | Required for the dual-specific Glu-tRNA(Gln) and Asp-tRNA(Asn) amidotransferase |
| tRNA(Asn) | Substrate tRNA that accepts aspartate to form Asp-tRNA(Asn) | Central to understanding nondiscriminating recognition |
| tRNA(Asp) | Substrate tRNA that can also be charged by the nondiscriminating enzyme | Used to compare active-site interactions with tRNA(Asp) versus tRNA(Asn) |
| Anticodon-binding domain of AspRS | Domain that recognizes the anticodon and contributes to tRNA specificity | Domain-swapping studies reveal contributions to catalysis |
| Conserved proline in anticodon-binding loop | Required for tRNA(Asn) recognition in vivo | Point mutations at this residue alter tRNA selection |
| L-aspartate | Amino acid substrate that is activated and transferred | Defines the substrate specificity of the activity |
| ATP | Energy source for aspartate activation | Required for adenylate formation |
| L-aspartol adenylate | Inhibitor that mimics the adenylate intermediate | Used to probe active-site differences between tRNA(Asp) and tRNA(Asn) |
| Glu-tRNA(Gln) amidotransferase | Dual-specific enzyme that also handles Asp-tRNA(Asn) | Links glutamine and asparagine decoding in Acidithiobacillus ferrooxidans |
| Asp-tRNA(Asn)/Glu-tRNA(Gln) amidotransferase | Complex that converts Asp-tRNA(Asn) to Asn-tRNA(Asn) | Kinase activity sensitive to distal mutations |
How Is aspartate-tRNA(Asn) ligase activity Regulated?
Aspartate-tRNA(Asn) ligase activity is regulated at the level of substrate availability, tRNA recognition, and coupling to the amidotransferase. The conserved proline in the anticodon-binding loop is required for tRNA(Asn) recognition in vivo, and mutation of this residue affects activity. Anticodon-binding domain swapping changes tRNA specificity and catalytic activity, indicating that domain interactions modulate function. A single amino acid substitution can alter activity and specificity in Plasmodium falciparum aspartyl and asparaginyl-tRNA synthetases. The downstream amidotransferase has kinase activity that is sensitive to distal mutations in its putative ammonia tunnel, suggesting that intramolecular communication regulates the coupled pathway. Inhibitors such as L-aspartol adenylate can block the synthetase step, providing a chemical means to regulate the activity.
aspartate-tRNA(Asn) ligase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PfAspRS | Malaria; parasite protein synthesis | Plasmodium falciparum knockout or point-mutation lines |
| PfAsnRS | Malaria; reaction hijacking inhibition | Parasite lines with tagged enzyme for inhibitor studies |
| H. pylori aspS | Bacterial infection; indirect aminoacylation | Helicobacter pylori knockout and complemented strains |
| gatA/gatB/gatC | Bacterial survival; tRNA-dependent amidation | Bacterial knockout and point-mutation models |
| aspS (E. coli model) | Bacterial growth; tRNA recognition | E. coli strains with anticodon-loop mutations |
Malaria and apicomplexan parasites
Plasmodium falciparum relies on aminoacyl-tRNA synthetases for protein synthesis, and reaction hijacking inhibition of its asparagine tRNA synthetase has been demonstrated, highlighting the potential of targeting this enzyme family in malaria. A single amino acid substitution can alter activity and specificity in P. falciparum aspartyl and asparaginyl-tRNA synthetases, which is relevant for understanding drug resistance and enzyme evolution.
Bacterial infections
Helicobacter pylori uses an Asp-tRNA(Asn)/Glu-tRNA(Gln) amidotransferase whose kinase activity is sensitive to distal mutations, indicating that the indirect aminoacylation pathway is important for bacterial survival and can be disrupted. Acidithiobacillus ferrooxidans uses a dual-specific amidotransferase to decode glutamine and asparagine codons, showing that this pathway is widespread among bacteria.
Antimicrobial and antiparasitic drug discovery
Because aspartate-tRNA(Asn) ligase activity is essential in several pathogens and differs from the human counterpart, it is a candidate for selective inhibition. Inhibitors that mimic the adenylate intermediate, such as L-aspartol adenylate, can block the enzyme and reveal active-site differences between tRNA(Asp) and tRNA(Asn). Reaction hijacking strategies further expand the chemical space for targeting this activity.
From aspartate-tRNA(Asn) ligase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the synthetase essential for growth? | CRISPR knockout of aspS in a pathogen or model bacterium |
| How does a specific residue affect tRNA(Asn) recognition? | Point mutation of the conserved proline in the anticodon-binding loop |
| Can domain swapping change tRNA specificity? | Knock-in of a swapped anticodon-binding domain |
| Where is the enzyme localized and when is it expressed? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression alter aminoacylation or growth? | Overexpression of aspS or its partners |
| Can inhibitors block the activity in cells? | Pathogen lines treated with adenylate mimics or reaction hijacking compounds |
How to Study the aspartate-tRNA(Asn) ligase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Aminoacylation assay | Formation of aspartyl-tRNA(Asx) | Testing wild-type and mutant synthetase activity |
| In vitro transcription | Synthesis of tRNA substrates | Probing tRNA recognition determinants |
| Steady-state kinetics | Catalytic efficiency and substrate affinity | Comparing tRNA(Asp) versus tRNA(Asn) charging |
| Inhibitor assays | Enzyme inhibition by adenylate mimics | Evaluating drug candidates |
| Site-directed mutagenesis | Effect of specific residues on activity | Testing conserved proline and active-site mutants |
| Domain swapping | Contribution of domains to specificity | Mapping anticodon-binding domain function |
| Knockout/complementation | Essentiality and rescue | Genetic validation in bacteria or parasites |
| Reaction hijacking | Pro-drug activation and inhibition | Antiparasitic drug discovery |
Aminoacylation and tRNA charging assays
Aminoacylation assays measure the formation of aspartyl-tRNA(Asx) using radiolabeled aspartate or tRNA gel electrophoresis. These assays are used to test the activity of wild-type and mutant synthetases, including anticodon-binding domain variants and proline mutants. They can also evaluate inhibitors such as L-aspartol adenylate.
In vitro transcription and tRNA recognition studies
In vitro transcribed tRNAs and mutant tRNA variants are used to dissect recognition determinants. Anticodon-binding domain swapping and point mutations reveal contributions to tRNA specificity and catalytic activity. These experiments help define why the enzyme is nondiscriminating.
Enzyme kinetics and inhibition
Steady-state kinetics with ATP, aspartate, and tRNA substrates quantify catalytic parameters. Inhibitor studies with adenylate analogs reveal differences between active-site interactions with tRNA(Asp) and tRNA(Asn). Reaction hijacking compounds can be tested for their ability to inhibit related synthetases.
Genetic and phenotypic analysis
Knockout, point-mutation, and complementation studies in bacteria or parasites link the activity to growth and survival. Mutations in the amidotransferase ammonia tunnel affect kinase activity, and single amino acid substitutions in Plasmodium synthetases alter activity and specificity. These approaches validate the essentiality of the pathway.
How CRISPR Can Be Used to Study GO:0050560 aspartate-tRNA(Asn) ligase activity
Knockout
CRISPR knockout of genes encoding aspartyl-tRNA synthetase or amidotransferase subunits can test essentiality and reveal growth defects. In bacteria and parasites, knockout of aspS or gat genes is expected to impair asparagine decoding and viability. Complementation with wild-type or mutant alleles can confirm specificity.
Point Mutation
Point mutations at the conserved proline in the anticodon-binding loop or at active-site residues can dissect tRNA(Asn) recognition and catalysis. Single amino acid substitutions in Plasmodium synthetases alter activity and specificity, providing a way to model resistance or enzyme evolution.
Knock-in
Knock-in of tagged synthetase or swapped anticodon-binding domains allows localization and interaction studies. Anticodon-binding domain swapping reveals contributions to tRNA specificity and catalytic activity. Tagged knock-in can also support inhibitor binding studies.
Overexpression
Overexpression of aspS or its partners can increase flux through the indirect aminoacylation pathway and enable biochemical purification. Overexpression systems are useful for testing whether elevated activity affects growth or aminoacylation. They also provide material for structural and kinetic studies.
How EDITGENE Supports aspartate-tRNA(Asn) ligase activity Research
Researchers studying aspartate-tRNA(Asn) ligase activity-related genes often need to determine whether a candidate gene is causally involved in tRNA charging, transamidation, or pathogen survival. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly.
Contact EDITGENE today to design your custom CRISPR model for aspartate-tRNA(Asn) ligase activity research.
Frequently Asked Questions About aspartate-tRNA(Asn) ligase activity
What is aspartate-tRNA(Asn) ligase activity?
It is a molecular function (GO:0050560) that catalyzes the ATP-dependent attachment of L-aspartate to tRNA(Asx), forming aspartyl-tRNA(Asx), diphosphate, and AMP.
What genes are involved in aspartate-tRNA(Asn) ligase activity?
Key genes include aspS encoding the nondiscriminating aspartyl-tRNA synthetase, and gatA, gatB, and gatC encoding the amidotransferase that converts Asp-tRNA(Asn) to Asn-tRNA(Asn).
Why is aspartate-tRNA(Asn) ligase activity important in bacteria?
It provides a route to decode asparagine codons in organisms that lack asparagine-tRNA synthetase, and it is essential for growth in several pathogens.
How is aspartate-tRNA(Asn) ligase activity different from aspartyl-tRNA synthetase activity?
The nondiscriminating enzyme can charge both tRNA(Asp) and tRNA(Asn) with aspartate, whereas a discriminating enzyme would only charge tRNA(Asp).
What reaction does GO:0050560 catalyze?
It catalyzes tRNA(Asx) + L-aspartate + ATP = aspartyl-tRNA(Asx) + diphosphate + AMP.
Can aspartate-tRNA(Asn) ligase activity be inhibited?
Yes, inhibitors such as L-aspartol adenylate mimic the adenylate intermediate and block the enzyme, and reaction hijacking strategies have been demonstrated for related synthetases.
What role does the anticodon-binding domain play?
The anticodon-binding domain contributes to tRNA specificity and catalytic activity, and domain-swapping experiments show its importance.
Why is a conserved proline important in this activity?
A conserved proline in the anticodon-binding loop is required for tRNA(Asn) recognition in vivo.
Which diseases are linked to this pathway?
Malaria and bacterial infections are linked because Plasmodium and Helicobacter rely on this pathway, making it a drug target.
How can CRISPR help study aspartate-tRNA(Asn) ligase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes such as aspS and gatA/B/C in cells and pathogens.
Conclusion
Aspartate-tRNA(Asn) ligase activity (GO:0050560) is a nondiscriminating aminoacyl-tRNA synthetase activity that enables indirect decoding of asparagine codons through Asp-tRNA(Asn) formation and transamidation. Its structural determinants, including the anticodon-binding domain and a conserved proline, have been mapped by mutagenesis and domain-swapping studies. The pathway is essential in several pathogens and is a promising target for inhibitor development. CRISPR-based models provide a direct way to test the causal roles of aspS, gatA, gatB, and gatC in this activity and its downstream biology.
References
- 1. Xie SC et al.. 2024. Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase.. Nat Commun 15(1):937 PMID: 38297033
- 2. Rathnayake UM et al.. 2019. Bacterial Aspartyl-tRNA Synthetase Has Glutamyl-tRNA Synthetase Activity.. Genes (Basel) 10(4) PMID: 30939863
- 3. Zhao L et al.. 2012. The kinase activity of the Helicobacter pylori Asp-tRNA(Asn)/Glu-tRNA(Gln) amidotransferase is sensitive to distal mutations in its putative ammonia tunnel.. Biochemistry 51(1):273-85 PMID: 22229412
- 4. Chuawong P et al.. 2020. Anticodon-binding domain swapping in a nondiscriminating aspartyl-tRNA synthetase reveals contributions to tRNA specificity and catalytic activity.. Proteins 88(9):1133-1142 PMID: 32067260
- 5. Sharma VK et al.. 2022. A single amino acid substitution alters activity and specificity in Plasmodium falciparum aspartyl & asparaginyl-tRNA synthetases.. Mol Biochem Parasitol 250:111488 PMID: 35644266
- 6. Feng L et al.. 2005. Aspartyl-tRNA synthetase requires a conserved proline in the anticodon-binding loop for tRNA(Asn) recognition in vivo.. J Biol Chem 280(21):20638-41 PMID: 15781458
- 7. Bernard D et al.. 2007. Inhibition by L-aspartol adenylate of a nondiscriminating aspartyl-tRNA synthetase reveals differences between the interactions of its active site with tRNA(Asp) and tRNA(Asn).. J Enzyme Inhib Med Chem 22(1):77-82 PMID: 17373551
- 8. Salazar JC et al.. 2001. A dual-specific Glu-tRNA(Gln) and Asp-tRNA(Asn) amidotransferase is involved in decoding glutamine and asparagine codons in Acidithiobacillus ferrooxidans.. FEBS Lett 500(3):129-31 PMID: 11445070
